Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Ross Labs nutritionals are 24% of Abbott's $9.2 bil. in 1994 sales; new products upcoming.

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

ROSS LABS NUTRITIONALS GENERATES 24% OF ABBOTT's $9.2 BIL. TOTAL SALES in 1994, or about $2.2 bil. worldwide, and have a "tre-mendous global potential" for growth in both the pediatric formula and the adult medical nutritional markets, Ross Labs Division President Tom McNally said at the Alex. Brown Twentieth Annual Health Care Seminar in Baltimore May 17. The worldwide nutritional products market was $7.4 bil. in 1994, McNally said, with $2.1 bil. generated by medical nutritionals and $5.3 bil. from pediatric nutritionals.

Table

View full table

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

EU Launches Critical Medicines Alliance But Prospect Of Act On Manufacturing Still Uncertain

‘Shocking’ MHRA Performance & Poor Data Transparency Blamed For UK’s Clinical Trial Crisis

Updated COVID-19 Vaccines Should Target New JN.1 Variant, Says EMA

EMA Pilots Partnering With Companies To Gain Efficiencies In Preparing Drug Assessment Reports

See All
UsernamePublicRestriction

Register

PS083850

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By